A meta-analysis of randomized controlled trials reported a risk ratio of 1.10 (95% CI, 0.86 to 1.41) for developing NEC among neonates receiving lactoferrin compared to placebo [17]. This evidence concerns the gene LTF and necrotizing enterocolitis.